熱門資訊> 正文
Quince Therapeutics宣布定价高达2200万美元的私募股权;股价上涨22%
2025-06-13 05:31
- Quince Therapeutics (NASDAQ:QNCX) announces a private placement expected to generate $11.5M in upfront proceeds.
- The deal includes common stock (or pre-funded warrants) and accompanying common warrants.
- Warrants could bring in an additional $10.4 M if exercised in full for cash.
- Funds will support working capital and general corporate purposes.
- QNCX shares rise 22% post-market on Thursday.
- Source: Press release
More on Quince Therapeutics
- Quince Therapeutics: Data In Ataxia-Telangiectasia Scheduled For Early 2026
- Seeking Alpha’s Quant Rating on Quince Therapeutics
- Historical earnings data for Quince Therapeutics
- Financial information for Quince Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
